FDA Inspection
Delaware Valley OB/GYN & Infertility Group P.C.Delaware Valley OB/GYN & Infertility Group P.C. – FDA Inspection, Mar 23, 2011
Record Details
This FDA Inspection record concerns Delaware Valley OB/GYN & Infertility Group P.C., with an inspection on March 23, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 23, 2011
- Product Type
- Biologics
View Company Profile
ID · f93777d1-9b5c-4ce9-b048-798a9b69692a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 715488
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.50(b)(1)Donor screening standards
- 21 CFR 1271.85(a)Infection with communicable disease agents
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
- 21 CFR 1271.47(a)Design of procedures to ensure compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Delaware Valley OB/GYN & Infertility Group P.C.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 21, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 30, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Delaware Valley OB/GYN & Infertility Group P.C.
- FDA Inspection 936825 - 2015-05-21
- FDA Inspection 842608 - 2013-07-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.